[go: up one dir, main page]

GB1106170A - Introduction of physiologically active substances into animal tissues - Google Patents

Introduction of physiologically active substances into animal tissues

Info

Publication number
GB1106170A
GB1106170A GB3997867A GB3997867A GB1106170A GB 1106170 A GB1106170 A GB 1106170A GB 3997867 A GB3997867 A GB 3997867A GB 3997867 A GB3997867 A GB 3997867A GB 1106170 A GB1106170 A GB 1106170A
Authority
GB
United Kingdom
Prior art keywords
physiologically active
sodium
agent
introduction
active material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3997867A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fort James Corp
Original Assignee
Crown Zellerbach Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crown Zellerbach Corp filed Critical Crown Zellerbach Corp
Publication of GB1106170A publication Critical patent/GB1106170A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method of introducing a physiologically active material into non-human animal tissue comprises contacting the tissue with effective amounts of a membrane penetrant composition comprising a dialkyl sulphoxide and a physiologically active material which is an antibacterial substance, e.g. iodine or sodium sulphadiazine, a vitamin, e.g. nicotinic acid, insulin, a steroid, a cytotoxic agent, e.g. methotrexate or thio-TEPA, a neuropharmacological agent, e.g. aminophylline, an antigen, a radiopaque agent, a diagnostic dye, e.g. Evans blue dye, heparin, a general anaesthetic, e.g. sodium pentobarbital, a local anaesthetic, e.g. procaine, an analgesic, e.g. sodium salicylate or an anti-histamine.
GB3997867A 1963-12-09 1964-12-08 Introduction of physiologically active substances into animal tissues Expired GB1106170A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32915163A 1963-12-09 1963-12-09
US32890863A 1963-12-09 1963-12-09

Publications (1)

Publication Number Publication Date
GB1106170A true GB1106170A (en) 1968-03-13

Family

ID=26986565

Family Applications (2)

Application Number Title Priority Date Filing Date
GB3997867A Expired GB1106170A (en) 1963-12-09 1964-12-08 Introduction of physiologically active substances into animal tissues
GB4320964A Expired GB1098151A (en) 1963-12-09 1964-12-08 Membrane penetrant compositions comprising dialkyl sulfoxides

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4320964A Expired GB1098151A (en) 1963-12-09 1964-12-08 Membrane penetrant compositions comprising dialkyl sulfoxides

Country Status (5)

Country Link
BR (1) BR6465159D0 (en)
ES (1) ES306377A1 (en)
GB (2) GB1106170A (en)
IL (1) IL22493A (en)
NL (1) NL140731B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2119248A (en) * 1982-04-28 1983-11-16 John Kenneth Mcmullen Insulin formulations and method of producing them

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
EP0189861A3 (en) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
AU775395B2 (en) * 1996-07-03 2004-07-29 Alza Corporation Non-aqueous polar aprotic peptide formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2119248A (en) * 1982-04-28 1983-11-16 John Kenneth Mcmullen Insulin formulations and method of producing them

Also Published As

Publication number Publication date
ES306377A1 (en) 1965-05-01
GB1098151A (en) 1968-01-10
BR6465159D0 (en) 1973-08-02
NL6414293A (en) 1965-06-10
NL140731B (en) 1974-01-15
IL22493A (en) 1968-10-24

Similar Documents

Publication Publication Date Title
ATE8790T1 (en) AROMATIC HETEROCYCLIC STEROID ESTER, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
SE8402551L (en) CINNAMOYLMORANOLIN DERIVATIVES
FR2285857A1 (en) MEDICAL CONTROL AGENT INTENDED TO BE ADMINISTERED BY INTRAVASCULAR ROUTE
ATE20518T1 (en) DRY POWDER ALLERGEN COMPOSITION AND PROCESS OF PRODUCTION.
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
ES426605A1 (en) A PROCEDURE FOR THE PREPARATION OF A VE-TERINARY COMPOSITION FOR THE TREATMENT OR PREVENTION OF MARIAL DISORDERS IN NON-HUMAN ANIMALS.
GB1106170A (en) Introduction of physiologically active substances into animal tissues
SE7514554L (en) ANTISEPTIC AND DISINFECTING COMPOSITIONS
DK131990C (en) AMINO-TRIJODPHENYL COMPOUNDS FOR USE AS X-RAY CONTRAST MEASURES AND METHODS FOR THE MANUFACTURE
IL37013A0 (en) Basically substituted alkylidene-aminooxyalkyl carboxylic acid esters,their preparation and pharmaceutical compositions containing them
SE391519B (en) SALDES OF IODMETAN SULPHONIC ACID WITH FLUCAMINE AND ITS ALKYLDERIVES INTENDED FOR USE AS X-RAY CONTRAST
DE3062300D1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them
DK138580C (en) 3-AMINO-2,4,6-TRIJODPHENYL OR OR BENZOYL ALKANIC ACIDS FOR USE AS X-RAY CONTRAST AGENTS
GB1381879A (en) Radiological examining process
JPS5695187A (en) Piperidine derivative of 33hydroxyythiophenee 22carboxylic acid ester* its manufacture and medicine containing it
DK127677B (en) X-ray contrast agent.
US3855405A (en) Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof
ZBYLSKI et al. The vascular structure of tubed pedicle flaps and the influence of surgical trauma
ES401603A1 (en) X-ray contrast agents
FI50040C (en) Method and apparatus for medical patient imaging.
HUP9903839A3 (en) Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence
GB917882A (en) Improvements relating to the testing of water for ph
BR7105296D0 (en) AN ACROPOL COMPOSITION ANTI-TRANSPIRANT AND DEODORANT AND PROCESS FOR ITS PREPARATION
AU249414B2 (en) X - ray contrast agent derived from 3,5 - diamino - 2,4,6 - triiodobenzoic acid
AU6707560A (en) X - ray contrast agent derived from 3,5 - diamino - 2,4,6 - triiodobenzoic acid